Compare Abbott India with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DR. REDDYS LAB - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DR. REDDYS LAB ABBOTT INDIA/
DR. REDDYS LAB
 
P/E (TTM) x 46.7 53.3 87.6% View Chart
P/BV x 15.2 5.3 285.2% View Chart
Dividend Yield % 0.5 0.5 90.8%  

Financials

 ABBOTT INDIA   DR. REDDYS LAB
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
DR. REDDYS LAB
Mar-20
ABBOTT INDIA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs8,8343,363 262.7%   
Low Rs5,4582,352 232.0%   
Sales per share (Unadj.) Rs1,731.11,054.2 164.2%  
Earnings per share (Unadj.) Rs211.9121.9 173.8%  
Cash flow per share (Unadj.) Rs219.9190.2 115.6%  
Dividends per share (Unadj.) Rs65.0025.00 260.0%  
Dividend yield (eoy) %0.90.9 104.0%  
Book value per share (Unadj.) Rs945.2938.7 100.7%  
Shares outstanding (eoy) m21.25166.17 12.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.12.7 152.3%   
Avg P/E ratio x33.723.4 143.9%  
P/CF ratio (eoy) x32.515.0 216.3%  
Price / Book Value ratio x7.63.0 248.4%  
Dividend payout %30.720.5 149.6%   
Avg Mkt Cap Rs m151,848474,831 32.0%   
No. of employees `0003.521.7 16.1%   
Total wages/salary Rs m4,35633,802 12.9%   
Avg. sales/employee Rs Th10,555.58,091.0 130.5%   
Avg. wages/employee Rs Th1,249.91,561.3 80.1%   
Avg. net profit/employee Rs Th1,292.2935.8 138.1%   
INCOME DATA
Net Sales Rs m36,786175,170 21.0%  
Other income Rs m1,1336,206 18.3%   
Total revenues Rs m37,919181,376 20.9%   
Gross profit Rs m6,04724,421 24.8%  
Depreciation Rs m16911,348 1.5%   
Interest Rs m23983 2.3%   
Profit before tax Rs m6,98918,296 38.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485-1,403 -177.1%   
Profit after tax Rs m4,50320,260 22.2%  
Gross profit margin %16.413.9 117.9%  
Effective tax rate %35.6-7.7 -463.7%   
Net profit margin %12.211.6 105.8%  
BALANCE SHEET DATA
Current assets Rs m27,610125,991 21.9%   
Current liabilities Rs m8,56972,141 11.9%   
Net working cap to sales %51.830.7 168.4%  
Current ratio x3.21.7 184.5%  
Inventory Days Days6073 82.4%  
Debtors Days Days27105 26.2%  
Net fixed assets Rs m1,05783,854 1.3%   
Share capital Rs m213831 25.6%   
"Free" reserves Rs m19,873155,157 12.8%   
Net worth Rs m20,086155,988 12.9%   
Long term debt Rs m01,304 0.0%   
Total assets Rs m29,409232,253 12.7%  
Interest coverage x311.619.6 1,588.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.8 165.8%   
Return on assets %15.49.1 168.3%  
Return on equity %22.413.0 172.6%  
Return on capital %34.912.6 276.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36984,193 0.4%   
Fx outflow Rs m4,91839,616 12.4%   
Net fx Rs m-4,54944,577 -10.2%   
CASH FLOW
From Operations Rs m4,99129,841 16.7%  
From Investments Rs m-2,570-4,923 52.2%  
From Financial Activity Rs m-1,428-25,159 5.7%  
Net Cashflow Rs m993-266 -373.4%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 5.4 146.3%  
FIIs % 0.1 35.3 0.3%  
ADR/GDR % 0.0 18.5 -  
Free float % 17.1 15.3 111.8%  
Shareholders   18,270 75,885 24.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  SHASUN PHARMA  PFIZER  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Plunges 746 Points; Banking & Metal Stocks Bleed(Closing)

Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 22, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - DIVIS LABORATORIES COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS